Cubist Systematic Strategies, LLC Cv Rx, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 39,922 shares of CVRX stock, worth $260,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,922
Previous 92,087
56.65%
Holding current value
$260,690
Previous $811,000
37.73%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CVRX
# of Institutions
94Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$26.8 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$13.2 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$6.02 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$5.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$5.72 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $134M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...